Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
The Journal of Head Trauma Rehabilitation
|
January 16, 2010
Sudden cardiac death and stroke with the use of antipsychotic medications: implications for clinicians treating individuals with traumatic brain injury
Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
July 11, 2002
A differential diagnostic approach to the pharmacological treatment of cognitive, behavioral, and affective disorders after traumatic brain injury
Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
June 13, 2003
The cytochrome p-450 drug metabolizing enzyme system: an overview of potential clinically important drug interactions
Bruno Wroblewski, Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
January 26, 2005
Twenty years of pharmacology
Mel B Glenn, Bruno Wroblewski
The Journal of Head Trauma Rehabilitation
|
June 13, 2003
Ginseng
Mel B Glenn, Jan Lexell
The Journal of Head Trauma Rehabilitation
|
July 13, 2004
Anterior pituitary dysfunction after traumatic brain injury, part II
Elie P Elovic, Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
October 14, 2005
Anticonvulsants
Mel B Glenn, Daniel B Hoch, Lisa Daly
Brain Injury
|
November 16, 2005
Characteristics of home-based community integration programmes for adults with brain injury
Mel B Glenn, Elizabeth A Selleck, Richard Goldstein, et al.
The Journal of Head Trauma Rehabilitation
|
September 20, 2005
Characteristics of residential community integration programs for adults with brain injury
Mel B Glenn, Michelle Rotman, Richard Goldstein, et al.
Journal of Neurotrauma
|
November 10, 2022
Response to Machamer et al., "Symptom Frequency and Persistence in the First Year after Traumatic Brain Injury: A TRACK-TBI Study" (doi: 10.1089/neu.2021.0348)
Bei Zhang, Daniel H Daneshvar, Ginger Polich, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
The Journal of Head Trauma Rehabilitation
|
January 16, 2010
Sudden cardiac death and stroke with the use of antipsychotic medications: implications for clinicians treating individuals with traumatic brain injury
Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
July 11, 2002
A differential diagnostic approach to the pharmacological treatment of cognitive, behavioral, and affective disorders after traumatic brain injury
Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
June 13, 2003
The cytochrome p-450 drug metabolizing enzyme system: an overview of potential clinically important drug interactions
Bruno Wroblewski, Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
January 26, 2005
Twenty years of pharmacology
Mel B Glenn, Bruno Wroblewski
The Journal of Head Trauma Rehabilitation
|
June 13, 2003
Ginseng
Mel B Glenn, Jan Lexell
The Journal of Head Trauma Rehabilitation
|
July 13, 2004
Anterior pituitary dysfunction after traumatic brain injury, part II
Elie P Elovic, Mel B Glenn
The Journal of Head Trauma Rehabilitation
|
October 14, 2005
Anticonvulsants
Mel B Glenn, Daniel B Hoch, Lisa Daly
Brain Injury
|
November 16, 2005
Characteristics of home-based community integration programmes for adults with brain injury
Mel B Glenn, Elizabeth A Selleck, Richard Goldstein, et al.
The Journal of Head Trauma Rehabilitation
|
September 20, 2005
Characteristics of residential community integration programs for adults with brain injury
Mel B Glenn, Michelle Rotman, Richard Goldstein, et al.
Journal of Neurotrauma
|
November 10, 2022
Response to Machamer et al., "Symptom Frequency and Persistence in the First Year after Traumatic Brain Injury: A TRACK-TBI Study" (doi: 10.1089/neu.2021.0348)
Bei Zhang, Daniel H Daneshvar, Ginger Polich, et al.
Page
of 3